Kurzzeitfasten unter Chemotherapie

Verbessert Kurzzeitfasten die Wirksamkeit einer Chemotherapie und vermindert Nebenwirkungen?

• Literatur

• 1 Harvie MN, Howell T. Could Intermittent Energy Restriction and Intermittent Fasting Reduce Rates of Cancer in Obese, Overweight, and Normal-Weight Subjects? A Summary of Evidence. Adv Nutr 2016; 7: 690-705
• 2 Gabel K, Hoddy KK, Haggerty N. et al. Effects of 8-hour time restricted feeding on body weight and metabolic disease risk factors in obese adults: A pilot study. Nutr Healthy Aging 2018; 4: 345-353
• 3 Dommerholt MB, Dionne DA, Hutchinson DF. et al. Metabolic effects of short-term caloric restriction in mice with reduced insulin gene dosage. J Endocrinol 2018; 237: 59-71
• 4 Wei M, Brandhorst S, Shelehchi M. et al. Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease. Sci Transl Med 2017; 9: pii:eaai8700
• 5 Michalsen A, Li C. Fasting therapy for treating and preventing disease – current state of evidence. Forsch Komplementmed 2013; 20: 444-453
• 6 Lv M, Zhu X, Wang H. et al. Roles of caloric restriction, ketogenic diet and intermittent fasting during initiation, progression and metastasis of cancer in animal models: a systematic review and meta-analysis. PLoS One 2014; 9: e115147
• 7 Antunes F, Erustes AG, Costa AJ. et al. Autophagy and intermittent fasting: the connection for cancer therapy?. Clinics (Sao Paulo) 2018; 73 (Suppl. 01) e814s
• 8 Castoldi F, Vacchelli E, Zitvogel L. et al. Systemic autophagy in the therapeutic response to anthracycline-based chemotherapy. Oncoimmunology 2019; 8: e1498285
• 9 van Niekerk G, Hattingh SM, Engelbrecht AM. Enhanced Therapeutic Efficacy in Cancer Patients by Short-term Fasting: The Autophagy Connection. Front Oncol 2016; 6: 242
• 10 Longo VD, Mattson MP. Fasting: Molecular Mechanisms and Clinical Applications. Cell Meta 2014; 19: 181-192
• 11 Raffaghello L, Lee C, Safdie FM. et al. Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy. Proc Natl Acad Sci U S A 2008; 105: 8215-8220
• 12 OʼFlanagan CH, Smith LA, McDonell SB. et al. When less may be more: calorie restriction and response to cancer therapy. BMC Med 2017; 15: 106
• 13 Caffa I, DʼAgostino V, Damonte P. et al. Fasting potentiates the anticancer activity of tyrosine kinase inhibitors by strengthening MAPK signaling inhibition. Oncotarget 2015; 6: 11820-11832
• 14 Di Biase S, Shim HS, Kim KH. et al. Fasting regulates EGR1 and protects from glucose- and dexamethasone-dependent sensitization to chemotherapy. PLoS Biol 2017; 15: e2001951
• 15 Pietrocola F, Pol J, Vacchelli E. et al. Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance. Cancer Cell 2016; 30: 147-160
• 16 Safdie FM, Dorff T, Quinn D. et al. Fasting and cancer treatment in humans: A case series report. Aging (Albany NY) 2009; 1: 988-1007
• 17 Dorff TB, Groshen S, Garcia A. et al. Safety and feasibility of fasting in combination with platinum-based chemotherapy. BMC Cancer 2016; 16: 360
• 18 De Groot S, Vreeswijk MP, Welters MJ. et al. The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study. BMC Cancer 2015; 15: 652
• 19 Bauersfeld SP, Kessler CS, Wischnewsky M. et al. The effects of short-term fasting on quality of life and tolerance to chemotherapy in patients with breast and ovarian cancer: a randomized cross-over pilot study. BMC Cancer 2018; 18: 476
• 20 Dorff TB, Shelechi M, Kang I. et al. A randomized phase II clinical trial of a fasting-mimic diet prior to chemotherapy to evaluate the impact on toxicity and efficacy. ASCO – Abstract 4. Juni 2018. Online: https://meetinglibrary.asco.org/record/165536/abstract ; Stand: 28.02.2019